Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma

Current guidelines for the diagnosis and treatment of osteoporosis do not address the risks to bone density and the likelihood of fracture that may be associated with inhaled corticosteroid treatment for asthma. This review outlines an approach to the use of bone densitometry in clinical practice fo...

Descripción completa

Detalles Bibliográficos
Autor principal: Toogood, John H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225820/
https://www.ncbi.nlm.nih.gov/pubmed/20529232
http://dx.doi.org/10.1186/1710-1492-1-1-28
_version_ 1782217530843070464
author Toogood, John H
author_facet Toogood, John H
author_sort Toogood, John H
collection PubMed
description Current guidelines for the diagnosis and treatment of osteoporosis do not address the risks to bone density and the likelihood of fracture that may be associated with inhaled corticosteroid treatment for asthma. This review outlines an approach to the use of bone densitometry in clinical practice for the diagnosis, prevention, and treatment of osteoporosis in asthmatic patients receiving inhaled corticosteroid therapy.
format Online
Article
Text
id pubmed-3225820
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32258202011-11-30 Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma Toogood, John H Allergy Asthma Clin Immunol Review Current guidelines for the diagnosis and treatment of osteoporosis do not address the risks to bone density and the likelihood of fracture that may be associated with inhaled corticosteroid treatment for asthma. This review outlines an approach to the use of bone densitometry in clinical practice for the diagnosis, prevention, and treatment of osteoporosis in asthmatic patients receiving inhaled corticosteroid therapy. BioMed Central 2005-03-15 /pmc/articles/PMC3225820/ /pubmed/20529232 http://dx.doi.org/10.1186/1710-1492-1-1-28 Text en Copyright ©2005 Canadian Society of Allergy and Clinical Immunology
spellingShingle Review
Toogood, John H
Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
title Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
title_full Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
title_fullStr Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
title_full_unstemmed Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
title_short Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
title_sort asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225820/
https://www.ncbi.nlm.nih.gov/pubmed/20529232
http://dx.doi.org/10.1186/1710-1492-1-1-28
work_keys_str_mv AT toogoodjohnh asthmaandtherapeuticsinhaledcorticosteroidscorticosteroidosteoporosisandtheriskoffractureinchronicasthma

Ejemplares similares